FundedIQ

Funded Startups in Parsippany

Recent Parsippany rounds in this slice span from 2020-12-17 (Medocity) to 2025-07-01 (Holistico), with four of the five entries closing between 2021 and 20…

Recent Parsippany rounds in this slice span from 2020-12-17 (Medocity) to 2025-07-01 (Holistico), with four of the five entries closing between 2021 and 2023 (2021-06-15 Northpass, 2023-09-27 Doceree, plus 2025-01-08 and 2025-07-01). On disclosed amounts, the largest is Doceree’s $35M (2023-09-27), which sits only modestly above Onkos Surgical’s $30M (2025-01-08), while the rest are lower at $11M (Medocity, 2020-12-17) and $4M (Northpass, 2021-06-15). The list also shows an outlier in disclosure status: Holistico (2025-07-01) is tagged “Angel” but its amount is undisclosed, so it can’t be compared to the disclosed range.

Sector-wise, Health Care appears twice (Onkos Surgical 2025-01-08; Doceree 2023-09-27; Medocity 2020-12-17), while Financial Services (Holistico) and Education (Northpass) and Advertising (Doceree) each appear once in this top-five view. Stage labels are fragmented: two rows have blank stage fields (Northpass in 2021; Medocity in 2020), two use named rounds (Onkos Surgical “Series Unknown” and Doceree “Series B”), and one entry is “undisclosed” on funding size (Holistico).

Most recent rounds

5 shown

Related listings

Frequently asked

What’s the largest disclosed round in Parsippany here, and how does it compare to other disclosed amounts?

Doceree’s $35M (2023-09-27) is the largest disclosed amount, narrowly above Onkos Surgical’s $30M (2025-01-08). The next disclosed amounts step down to $11M (Medocity, 2020-12-17) and $4M (Northpass, 2021-06-15).

Do these recent financings cluster in time, or are they evenly spread across years?

They’re clustered around the 2020–2023 period with three of the five entries closing in that window: Medocity (2020-12-17), Northpass (2021-06-15), and Doceree (2023-09-27). The other two close later, in 2025: Onkos Surgical (2025-01-08) and Holistico (2025-07-01).

Is there an outlier worth attention due to disclosure or amount scale?

Holistico (2025-07-01) is an outlier on comparability because the round amount is “undisclosed” despite being labeled “Angel.” On the disclosed side, the spread is driven by Doceree’s $35M and Onkos Surgical’s $30M versus the much smaller $11M (Medocity) and $4M (Northpass).

Which sectors are over-represented among these five most recent entries?

Health Care appears in three entries (Onkos Surgical on 2025-01-08, Medocity on 2020-12-17, and Doceree on 2023-09-27), while Financial Services (Holistico), Education (Northpass), and Advertising (Doceree) each show up as single entries in this top-five slice.

How does the stage mix look, and does it affect how amounts can be compared?

Stage labeling is uneven: two rows leave the stage blank (Northpass on 2021-06-15; Medocity on 2020-12-17), one is “Series Unknown” (Onkos Surgical on 2025-01-08), and one is explicitly “Series B” (Doceree on 2023-09-27). Holistico (2025-07-01) is “Angel” but with an undisclosed amount, limiting cross-stage comparisons for the most recent entry.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.